ACAD ACADIA PHARMACEUTICALS INC

8-K Current Report

Filed: February 25, 2026

Health Care

Pharmaceutical Preparations

ACADIA PHARMACEUTICALS INC (ACAD) 8-K current report filed with SEC EDGAR on February 25, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
1 item

Item 2.02: Results of Operations and Financial Condition

AI Filing Analysis
8-K

Item 2.02 · Results of Operations and Financial Condition

• Q4 and full-year 2025 financial results announced Feb 25, 2026; details in Exhibit 99.1
• Full results (revenue, earnings, guidance) contained in press release — key figures require review of Exhibit 99.1

Other ACADIA PHARMACEUTICALS INC 8-K Filings

8-K Mar 5, 2026

Get deeper insights on ACADIA PHARMACEUTICALS INC

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.